{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:51:58Z","timestamp":1793317918580,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T00:00:00Z","timestamp":1536624000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["2 R01 DK083402-06A1"],"award-info":[{"award-number":["2 R01 DK083402-06A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"name":"College of Medicine Bridge","award":["1U19AI116491-01"],"award-info":[{"award-number":["1U19AI116491-01"]}],"id":[{"id":"https:\/\/ror.org\/059qmz715","id-type":"ROR","asserted-by":"crossref"}]},{"name":"University of Cincinnati Graduate School","award":["2T32GM105526-04"],"award-info":[{"award-number":["2T32GM105526-04"]}],"id":[{"id":"https:\/\/ror.org\/01e3m7079","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100005277","name":"PHS","doi-asserted-by":"publisher","award":["P30 DK078392"],"award-info":[{"award-number":["P30 DK078392"]}],"id":[{"id":"10.13039\/100005277","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","cmghjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"published-print":{"date-parts":[[2019]]},"DOI":"10.1016\/j.jcmgh.2018.09.008","type":"journal-article","created":{"date-parts":[[2018,9,20]],"date-time":"2018-09-20T20:57:30Z","timestamp":1537477050000},"page":"161-184","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["An Organoid-Based Preclinical Model of Human Gastric Cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Nina G.","family":"Steele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayati","family":"Chakrabarti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"Biesiada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loryn","family":"Holokai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren M.","family":"Nowacki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2560-193X","authenticated-orcid":false,"given":"Maxime","family":"Mahe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nambirajan","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5934-2852","authenticated-orcid":false,"given":"Noah","family":"Shroyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Medvedovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Helmrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2384-3775","authenticated-orcid":false,"given":"Yana","family":"Zavros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcmgh.2018.09.008_bib1","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1067\/j.cpsurg.2016.08.001","article-title":"An update on gastric cancer","volume":"53","author":"Ahmad","year":"2016","journal-title":"Curr Probl Surg"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib2","first-page":"281","article-title":"Epidemiology of gastric cancer","volume":"23","author":"Neugut","year":"1996","journal-title":"Semin Oncol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/1758834012469429","article-title":"Gastric cancer and trastuzumab: first biologic therapy in gastric cancer","volume":"5","author":"Gunturu","year":"2013","journal-title":"Ther Adv Med Oncol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1309\/AJCPIP5LOO3NGDJG","article-title":"A\u00a0comparison of equivocal immunohistochemical results with anti-HER2\/neu antibodies A0485 and SP3 with corresponding FISH results in routine clinical practice","volume":"135","author":"Manion","year":"2011","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib5","first-page":"65","article-title":"Comparison of HER2 gene amplification assessed by fluorescence in situ hybridization and HER2 protein expression assessed by immunohistochemistry in gastric cancer","volume":"15","author":"Yano","year":"2006","journal-title":"Oncol Rep"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib6","doi-asserted-by":"crossref","first-page":"6438","DOI":"10.3748\/wjg.v19.i38.6438","article-title":"HER2 in gastric cancer: comparative analysis of three different antibodies using whole-tissue sections and tissue microarrays","volume":"19","author":"Abrahao-Machado","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib7","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib8","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/1476-4598-5-55","article-title":"Pathway-specific differences between tumor cell lines and normal and tumor tissue cells","volume":"5","author":"Ertel","year":"2006","journal-title":"Mol Cancer"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib9","doi-asserted-by":"crossref","first-page":"18708","DOI":"10.1073\/pnas.1111840108","article-title":"Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance","volume":"108","author":"Gillet","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib10","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1073\/pnas.0408105102","article-title":"Assessment of tumor characteristic gene expression in cell lines using a tissue similarity index (TSI)","volume":"102","author":"Sandberg","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.2174\/1389450043345489","article-title":"Intractable cancers: the many faces of multidrug resistance and the many targets it presents for therapeutic attack","volume":"5","author":"Stein","year":"2004","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib12","doi-asserted-by":"crossref","first-page":"e58","DOI":"10.1016\/S1470-2045(13)70477-7","article-title":"The immune system and response to HER2-targeted treatment in breast cancer","volume":"15","author":"Bianchini","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib13","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1182\/blood-2008-12-195792","article-title":"Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired","volume":"114","author":"Ahmadzadeh","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib14","doi-asserted-by":"crossref","first-page":"e95475","DOI":"10.1371\/journal.pone.0095475","article-title":"Intratumoral CD8(+) cytotoxic lymphocyte is a favorable prognostic marker in node-negative breast cancer","volume":"9","author":"Chen","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib15","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1172\/JCI74894","article-title":"Tumor-specific cytotoxic T lymphocyte activity determines colorectal cancer patient prognosis","volume":"125","author":"Reissfelder","year":"2015","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.acthis.2006.01.003","article-title":"Immunohistochemical localization of programmed death-1 ligand-1 (PD-L1) in gastric carcinoma and its clinical significance","volume":"108","author":"Wu","year":"2006","journal-title":"Acta Histochem"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2217\/imt-2016-0025","article-title":"PD-L1 expression and outcome of advanced melanoma patients treated with anti-PD-1\/PD-L1 agents: a meta-analysis","volume":"8","author":"Abdel-Rahman","year":"2016","journal-title":"Immunotherapy"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib18","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.critrevonc.2016.03.007","article-title":"Correlation between PD-L1 expression and outcome of NSCLC patients treated with anti-PD-1\/PD-L1 agents: a meta-analysis","volume":"101","author":"Abdel-Rahman","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib19","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.critrevonc.2015.08.015","article-title":"Immune checkpoints aberrations and gastric cancer: assessment of prognostic value and evaluation of therapeutic potentials","volume":"97","author":"Abdel-Rahman","year":"2016","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib20","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000335694","article-title":"Cytokeratin expression profiling in gastric carcinoma: clinicopathologic significance and comparison with tumor-associated molecules","volume":"79","author":"Takami","year":"2012","journal-title":"Pathobiology"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib21","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1046\/j.1365-2559.2002.01387.x","article-title":"Keratin expression in human tissues and neoplasms","volume":"40","author":"Chu","year":"2002","journal-title":"Histopathology"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib22","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1038\/s41598-017-19025-y","article-title":"An orthotopic mouse model of gastric cancer invasion and metastasis","volume":"8","author":"Busuttil","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib23","article-title":"Human gastric cancer modelling using organoids","author":"Seidlitz","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib24","doi-asserted-by":"crossref","first-page":"794","DOI":"10.4049\/jimmunol.1202088","article-title":"Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8\/A9 proinflammatory proteins","volume":"190","author":"Wang","year":"2013","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib25","doi-asserted-by":"crossref","first-page":"95083","DOI":"10.18632\/oncotarget.18297","article-title":"The peripheral immune status of granulocytic myeloid-derived suppressor cells correlates the survival in advanced gastric cancer patients receiving cisplatin-based chemotherapy","volume":"8","author":"Shoji","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib26","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00428-010-0952-2","article-title":"HER2 diagnostics in gastric cancer-guideline validation and development of standardized immunohistochemical testing","volume":"457","author":"Ruschoff","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1126\/science.3798106","article-title":"Human breast cancer: correlation of relapse and survival with amplification of the HER-2\/neu oncogene","volume":"235","author":"Slamon","year":"1987","journal-title":"Science"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib28","doi-asserted-by":"crossref","first-page":"e1004663","DOI":"10.1371\/journal.ppat.1004663","article-title":"CD44 plays a functional role in Helicobacter pylori-induced epithelial cell proliferation","volume":"11","author":"Bertaux-Skeirik","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcmgh.2016.05.004","article-title":"The development of spasmolytic polypeptide\/TFF2-expressing metaplasia (SPEM) during gastric repair is absent in the aged stomach","volume":"2","author":"Engevik","year":"2016","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib30","first-page":"1","article-title":"Oncogenic transformation of human-derived gastric organoids","author":"Bertaux-Skeirik","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1038\/nmeth.3252","article-title":"Orchestrating high-throughput genomic analysis with Bioconductor","volume":"12","author":"Huber","year":"2015","journal-title":"Nat Meth"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib32","doi-asserted-by":"crossref","first-page":"R106","DOI":"10.1186\/gb-2010-11-10-r106","article-title":"Differential expression analysis for sequence count data","volume":"11","author":"Anders","year":"2010","journal-title":"Genome Biol"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib33","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J\u00a0Roy Stat Soc B"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a Bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib35","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1471-2105-11-234","article-title":"A\u00a0semi-parametric Bayesian model for unsupervised differential co-expression analysis","volume":"11","author":"Freudenberg","year":"2010","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib36","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1471-2105-10-234","article-title":"CLEAN: CLustering Enrichment ANalysis","volume":"10","author":"Freudenberg","year":"2009","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/j.jcmgh.2018.09.008_bib37","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"}],"container-title":["Cellular and Molecular Gastroenterology and Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X18301309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352345X18301309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T11:38:36Z","timestamp":1720611516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352345X18301309"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019]]}},"alternative-id":["S2352345X18301309"],"URL":"https:\/\/doi.org\/10.1016\/j.jcmgh.2018.09.008","relation":{},"ISSN":["2352-345X"],"issn-type":[{"value":"2352-345X","type":"print"}],"subject":[],"published":{"date-parts":[[2019]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An Organoid-Based Preclinical Model of Human Gastric Cancer","name":"articletitle","label":"Article Title"},{"value":"Cellular and Molecular Gastroenterology and Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcmgh.2018.09.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier Inc. on behalf of the AGA Institute.","name":"copyright","label":"Copyright"}]}}